Yong-Ri Jin
- Molecular Biology
- Oncology
- Organic Chemistry
- Pharmacology top 10%
- Biochemistry top 5%
- Co-authors
- Jeong Kyo YoonYeo‐Pyo YunTack‐Joong KimXiang HanJung‐Jin LeeMi‐Ra ChoYong LimXianghua Han
- Topics
- Antiplatelet Therapy and Cardiovascular Diseases (6 papers)Bioactive Compounds and Antitumor Agents (5 papers)Phytochemical Studies and Bioactivities (4 papers)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Yong-Ri Jin
42 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 110
- Molecular Biology 687
- Oncology 164
- Organic Chemistry 149
- Pharmacology 144
- Biochemistry 141
Countries citing papers authored by Yong-Ri Jin
This map shows the geographic impact of Yong-Ri Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong-Ri Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong-Ri Jin more than expected).
Fields of papers citing papers by Yong-Ri Jin
This network shows the impact of papers produced by Yong-Ri Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong-Ri Jin. The network helps show where Yong-Ri Jin may publish in the future.
Co-authorship network of co-authors of Yong-Ri Jin
This figure shows the co-authorship network connecting the top 25 collaborators of Yong-Ri Jin. A scholar is included among the top collaborators of Yong-Ri Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong-Ri Jin. Yong-Ri Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 102 | |
| 3 | 89 | |
| 4 | 31 | |
| 5 | 38 | |
| 6 | 40 | |
| 7 | 15 | |
| 8 | 1 | |
| 9 | 12 | |
| 10 | 12 | |
| 11 | 37 | |
| 12 | 24 | |
| 13 | 26 | |
| 14 | 16 | |
| 15 | 20 | |
| 16 | 74 | |
| 17 | 33 | |
| 18 | 52 | |
| 19 | 26 | |
| 20 | 2 |
About Yong-Ri Jin
Yong-Ri Jin is a scholar working on Toxicology, Pharmacology and Cancer Research, having authored 42 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Phytochemical Studies and Bioactivities (4 papers). The work is most often cited by research in Biochemistry (141 citations), Toxicology (59 citations) and Complementary and alternative medicine (98 citations). Yong-Ri Jin has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Jeong Kyo Yoon, Yeo‐Pyo Yun, Tack‐Joong Kim, Xiang Han, Jung‐Jin Lee, Mi‐Ra Cho, Yong Lim, Xianghua Han, Hwan‐Soo Yoo and Marianne L. Seto. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.